Originally developed to replace phencyclidine (PCP) for anesthetic and analgesic purposes, ketamine is now known to exert antidepressant actions in the brain. Research suggests ketamine relieves symptoms of treatment-resistant depression by stopping specific receptors and regions in the brain from releasing chemicals involved in depression.